STOCK TITAN

CONMED Corporation to Announce Second Quarter 2022 Financial Results on July 27, 2022

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) will report its second quarter 2022 financial results after market close on July 27, 2022. A conference call to discuss these results will be hosted by the company's management at 4:30 p.m. ET on the same day. Interested participants can pre-register for the call to obtain the dial-in number and passcode or access the webcast via the Investors section of CONMED's website. The replay will be available one hour post-call.

Positive
  • None.
Negative
  • None.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2022 after the market close on Wednesday, July 27, 2022. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.

To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode.

This conference call will also be webcast and can be accessed from the “Investors” section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release and the associated conference call may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2021 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

Chief Financial Officer

ToddGarner@conmed.com

CONMED Corporation

Todd W. Garner

727-214-2975

Source: CONMED Corporation

FAQ

When will CONMED Corporation report its second quarter 2022 financial results?

CONMED Corporation will report its second quarter 2022 financial results after market close on July 27, 2022.

What time is the CONMED Corporation conference call on July 27, 2022?

The CONMED Corporation conference call is scheduled for 4:30 p.m. ET on July 27, 2022.

How can I access the CONMED Corporation conference call?

You can access the CONMED Corporation conference call by pre-registering to obtain the dial-in number or by accessing the webcast on the Investors section of CONMED's website.

CONMED Corporation

NYSE:CNMD

CNMD Rankings

CNMD Latest News

CNMD Stock Data

2.17B
30.70M
0.58%
114.64%
7.66%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
LARGO